MAH (Marketing Authorization Holder) in EU market

Based on the great success of our past events in Life Science Industry, namely Biopharma & VacTech China Congress, "the 4th Annual Biopharma China Congress 2014" is organized now aiming at continuously creating the best platform for biopharma professionals in China.
 
This year's event will be discussing the hottest issues with 5 chapters focusing on Vaccine Technology, Antibody, Protein Drugs, Cell Culture and Biopharma. More than 40 senior speakers from the leading companies will be invited to share their best practice in the field of New Generation Vaccine, Adjuvant, Optimization of Cell Strain & Protein Expression, Cell Culture Development, Large Scale Manufacturing, Biosimilar, and Explanation to Newest Regulation & Marketing Development. 16 networking slots with more than 560 minutes will be provided to the attending companies to look into future cross-boarder growth opportunities and reach for new strategic focus!